Last $33.35 USD
Change Today -0.27 / -0.80%
Volume 222.8K
BRLI On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gary Lederman Esq.

Former Director, Chairman of Audit Committee, Member of Nominating Committee and Member of Compensation Committee, Bio-Reference Laboratories Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

78$118,000

Background*

Mr. Gary Lederman, Esq. served as a Manager of Locals 370, 491 and 662 of the U.F.C.W. International Union from 1961 to 1985. Mr. Lederman was a retired from the unions and was a Lecturer at Queensboro Community College in the field of insurance. He served on an Institutional Review Board for RTL, a pharmaceutical drug testing laboratory. He served as a Director of Bio-Reference Laboratories Inc. since May 1997. He holded a BA degree from Brooklyn College in 1954 and ...

Read Full Background

Corporate Headquarters*

481 Edward H. Ross Drive
Elmwood Park, New Jersey 07407

United States

Phone: 201-791-2600
Fax: --

Board Members Memberships*

1997-N/A
Former Director, Chairman of Audit Committee, Member of Nominating Committee and Member of Compensation Committee

Education*

BA 1954
Brooklyn College
JD 1957
New York University School Of Law

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$118,000
Total Calculated Compensation$118,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRLI:US $33.35 USD -0.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter D. Meldrum Ph.D.Chief Executive Officer, President and Director
Myriad Genetics Inc.
$997.0K
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$400.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-REFERENCE LABS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.